HNF4A and prostate cancer: Additionally, ZNF433 is significantly upregulated in prostate cancer, where it promotes cancer cell proliferation, migration, and tumorigenicity by activating the β-catenin/TCF signaling pathway, making it a potential therapeutic target for prostate cancer (17).